Skip to Content

21 Results Found

  • Article
  • Open Access
9 Citations
5,679 Views
10 Pages

The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice Treated with Antiglaucoma Eye Medications

  • Yukari Yagi-Yaguchi,
  • Takashi Kojima,
  • Kazunari Higa,
  • Murat Dogru and ,
  • Osama MA. Ibrahim,
  • Takahiko Shimizu,
  • Kazuo Tsubota and
  • Jun Shimazaki
  • + 3 authors+ 0 author

Anti-glaucoma eye drop treatment often induces dry eyes and can lead to poor medication adherence. This study aimed to investigate the effects of 3% diquafosol sodium eye drops on tear function and the ocular surface epithelium in Sod1−/−...

(This article belongs to the Special Issue Dry Eye and Ocular Surface Disorders)
  • Article
  • Open Access
8 Citations
3,647 Views
13 Pages

The Effect of High Molecular Weight Hyaluronic Acid and Latanoprost Eyedrops on Tear Functions and Ocular Surface Status in C57/BL6 Mice

  • Murat Dogru,
  • Takashi Kojima,
  • Kazunari Higa,
  • Ayako Igarashi and ,
  • Haruka Kudo,
  • Wolfgang G. K. Müller-Lierheim,
  • Kazuo Tsubota and
  • Kazuno Negishi
  • + 3 authors+ 0 author

9 January 2023

Anti-glaucoma eye drop treatment often induces ocular surface problems, including dry eyes, and may be associated with poor medication compliance. This study aimed to investigate the effects of a novel high molecular weight hyaluronic acid and Latano...

(This article belongs to the Special Issue Advances in Dry Eye Disease Treatment)
  • Communication
  • Open Access
5 Citations
3,055 Views
10 Pages

Therapeutic Aqueous Humor Concentrations of Latanoprost Attained in Rats by Administration in a Very-High-Molecular-Weight Hyaluronic Acid Eye Drop

  • Kazunari Higa,
  • Reona Kimoto,
  • Takashi Kojima,
  • Murat Dogru and ,
  • Wolfgang G. K. Müller-Lierheim and
  • Jun Shimazaki
  • + 1 author+ 0 author

The temporal change in concentration of a novel medicine, Latanoprost (LP), was evaluated in the aqueous humor of rats (6–8-week-old Jcl:Wister rats) when delivered in a very-high-molecular-weight hyaluronic acid (vHiHA) eye drop. Animals were...

(This article belongs to the Special Issue Advances in Ocular Drug Delivery)
  • Article
  • Open Access
2,893 Views
10 Pages

A Case Series of Transscleral Cyclophotocoagulation Nd:YAG Laser in Refractory Glaucoma

  • Gregorio Lo Giudice,
  • Giuseppe Miceli,
  • Giuseppe Tumminello,
  • Alessandro Trapani and
  • Antonino Pioppo

Purpose: To describe the efficacy and safety of surgical treatment in refractory glaucoma using transscleral cyclophotocoagulation with a diode laser (TSCPC). Cyclo-G6 laser with a G-probe delivery system (Iridex, Silicon Valley, CA, USA). Materials...

  • Article
  • Open Access
5 Citations
2,495 Views
11 Pages

Outcomes of Endoscopic Endonasal Dacryocystorhinostomy in Glaucoma Patients

  • Gian Marco Pace,
  • Francesco Giombi,
  • Giovanna Muci,
  • Gianmarco Giunta and ,
  • Francesca Pirola,
  • Egidio Serra,
  • Jessica Zuppardo,
  • Fabio Ferreli,
  • Paolo Vinciguerra and
  • Luca Malvezzi
  • + 8 authors+ 3 authors

27 March 2024

Background: Anti-glaucoma eye drops have been investigated due to their production of fibrotic changes on the conjunctival surface, undermining the functioning of the upper lacrimal drainage system. We aimed to assess whether these effects may impair...

(This article belongs to the Section Personalized Therapy and Drug Delivery)
  • Article
  • Open Access
6,208 Views
9 Pages

Latanoprost PF vs. Bimatoprost PF: Which Treats the Ocular Surface Better?

  • Georgios S. Dimtsas,
  • Anastasia Tsiogka and
  • Marilita M. Moschos

25 October 2023

(1) Background: The current study aimed to compare two of the most frequently prescribed preservative-free (PF) antiglaucoma drops, (Latanoprost PF vs. Bimatoprost PF) in promoting OSD in patients with POAG. (2) Methods: In this prospective study, 44...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
9 Citations
2,766 Views
10 Pages

Paul Glaucoma Implant following Congenital Cataract Surgery in a Pediatric Cohort

  • Angi Lizbeth Mendoza-Moreira,
  • Anna Maria Voigt,
  • Julia V. Stingl,
  • Jasmin Rezapour and ,
  • Felix Mathias Wagner,
  • Alexander K. Schuster and
  • Esther M. Hoffmann
  • + 2 authors+ 0 author

15 May 2024

Background: The aim of this study was to evaluate the short-term efficacy and safety of the Paul Glaucoma Implant (PGI) in pediatric eyes diagnosed with glaucoma following congenital cataract surgery (GFCS). Methods: A retrospective, single-center, d...

(This article belongs to the Section Ophthalmology)
  • Review
  • Open Access
43 Citations
6,418 Views
18 Pages

Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma

  • Hassan A. Albarqi,
  • Anuj Garg,
  • Mohammad Zaki Ahmad,
  • Abdulsalam A. Alqahtani and ,
  • Ismail A. Walbi and
  • Javed Ahmad
  • + 1 author+ 0 author

Glaucoma is a degenerative, chronic ocular disease that causes irreversible vision loss. The major symptom of glaucoma is high intraocular pressure, which happens when the flow of aqueous humor between the front and back of the eye is blocked. Glauco...

(This article belongs to the Special Issue Nanoparticles in Ocular Drug Delivery Systems)
  • Article
  • Open Access
4 Citations
5,512 Views
12 Pages

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs

  • Mizuki Kita,
  • Kazutaka Kanai,
  • Hiroki Mitsuhashi,
  • Tomoki Noguchi and ,
  • Noriaki Nagai,
  • Mizuki Yamaguchi,
  • Yuya Otaka,
  • Rina Kudo,
  • Yohei Yamashita and
  • Kazuki Tajima
  • + 5 authors+ 0 author

23 August 2021

Timolol maleate (TM), a beta-adrenergic receptor antagonist, is widely used for canine antiglaucoma eye drops; however, its bioavailability is <5%. Our previous study revealed that magnesium hydroxide nanoparticles (nMH) have potency in improving...

(This article belongs to the Special Issue Advances in Veterinary and Comparative Ophthalmology)
  • Article
  • Open Access
4 Citations
2,405 Views
10 Pages

Comparison of Corvis ST Parameters between Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma

  • Yuta Nakaniida,
  • Kana Tokumo,
  • Hiromitsu Onoe,
  • Naoki Okada and ,
  • Shunsuke Nakakura,
  • Ryo Asaoka and
  • Yoshiaki Kiuchi
  • + 2 authors+ 0 author

3 August 2023

Background: We compared corneal visualization Scheimpflug technology (CST) parameters between eyes with primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG). Methods: A retrospective analysis was performed on data from 89 eyes...

(This article belongs to the Special Issue Recommendations for Clinical Management of Glaucoma)
  • Article
  • Open Access
5 Citations
2,172 Views
14 Pages

11 October 2023

Background: This is a report of 3-year results of a prospective assessment of three modifications of canaloplasty (C): ab externo (ABeC), mini-canaloplasty (miniABeC), and ab interno (ABiC) performed concomitantly with cataract removal in subjects su...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
4 Citations
2,365 Views
10 Pages

17 September 2021

Background: We evaluated the safety and efficacy of endoscopic cyclophotocoagulation (ECP) for eyes with primary open-angle glaucoma (POAG). Methods: We included a total of 104 pseudophakic eyes treated with ECP. Visual acuity and intraocular pressur...

(This article belongs to the Special Issue Novel Therapeutics in Glaucoma Management)
  • Review
  • Open Access
34 Citations
5,761 Views
17 Pages

30 July 2020

The coronavirus disease 2019 (COVID-19) represents a global concern of public health caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Its clinical manifestations are characterized by a heterogeneous group of symptoms and pictur...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
1 Citations
2,037 Views
12 Pages

Clinical Outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy in Eyes After Failed Trabeculectomy

  • Agnieszka Ćwiklińska-Haszcz,
  • Dominika Wróbel-Dudzińska and
  • Ewa Kosior-Jarecka

17 September 2025

Background: This study aims to present the clinical outcomes, safety profile, and mid-term results of gonioscopy-assisted transluminal trabeculotomy (GATT) in eyes with failed trabeculectomy. Methods: The studied group consisted of 62 patients after...

(This article belongs to the Special Issue Clinical Debates in Minimally Invasive Glaucoma Surgery (MIGS))
  • Article
  • Open Access
152 Citations
5,614 Views
18 Pages

5 October 2010

The poor bioavailability and therapeutic response exhibited by conventional ophthalmic preparations due to rapid precorneal elimination, dilution and nasolacrimal drainage of the drug may be vanquished by the use of in situ gelling systems that are...

  • Article
  • Open Access
4 Citations
3,317 Views
13 Pages

Outcomes of Deep Sclerectomy following Failed XEN Gel Stent Implantation in Open-Angle Glaucoma: A Prospective Study

  • Giorgio Enrico Bravetti,
  • Kevin Gillmann,
  • Harsha L. Rao,
  • André Mermoud and
  • Kaweh Mansouri

16 August 2022

Background: The purpose of this study is to evaluate the outcome of deep sclerectomy (DS) as a secondary procedure following failed ab-interno XEN gel stent implantation in patients with open-angle glaucoma. Methods: Prospective, single-center, non-r...

(This article belongs to the Special Issue Advances in Glaucoma Surgery)
  • Article
  • Open Access
8 Citations
4,123 Views
11 Pages

15 October 2024

Objectives: This study aimed to evaluate the postoperative outcomes of the PreserFlo MicroShunt in Asian patients with exfoliation glaucoma. Methods: We used the Kaplan–Meier method to analyze 29 eyes of 29 patients with exfoliation glaucoma (m...

(This article belongs to the Special Issue Clinical Debates in Minimally Invasive Glaucoma Surgery (MIGS))
  • Review
  • Open Access
10 Citations
4,821 Views
25 Pages

Technological Advances in a Therapy of Primary Open-Angle Glaucoma: Insights into Current Nanotechnologies

  • Julita Zembala,
  • Alicja Forma,
  • Roksana Zembala,
  • Jacek Januszewski and ,
  • Patryk Zembala,
  • Dominik Adamowicz,
  • Grzegorz Teresiński,
  • Grzegorz Buszewicz,
  • Jolanta Flieger and
  • Jacek Baj
  • + 5 authors+ 0 author

6 September 2023

Glaucoma is a leading cause of irreversible blindness and is characterized by increased intraocular pressure (IOP) and progressive optic nerve damage. The current therapeutic approaches for glaucoma management, such as eye drops and oral medications,...

(This article belongs to the Special Issue Diagnosis, Treatment, and Prevention of Glaucoma)
  • Article
  • Open Access
11 Citations
4,393 Views
10 Pages

Effectiveness of Topical Ganciclovir 2% Monotherapy Versus Combined Steroid Therapy in Cytomegalovirus Endotheliitis

  • Yu-Wei Kuo,
  • En-Che Chang,
  • Chia-Yi Lee,
  • Shwu-Huey Lee and ,
  • I-Chia Liang,
  • Yi-Chun Chen and
  • Yu-Chih Hou
  • + 2 authors+ 0 author

30 September 2022

We aimed to report the clinical manifestations of cytomegalovirus (CMV) corneal endotheliitis and the results of long-term treatment with topical ganciclovir 2% with and without steroids. This retrospective, interventional study included 15 eyes of 1...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
1 Citations
1,135 Views
9 Pages

Effect of Combined Cataract and Minimally Invasive Glaucoma Surgeries on Glaucoma-Specific Quality of Life

  • Jonathan T. W. Au Eong,
  • Jin Rong Low,
  • Eva K. Fenwick,
  • Hla M. Htoon and ,
  • Shamira A. Perera,
  • Tina T. Wong,
  • Ecosse L. Lamoureux and
  • Ryan E. K. Man
  • + 3 authors+ 0 author

4 February 2026

Background: Minimally invasive glaucoma surgery, often performed with phacoemulsification (PHACO-MIGS), for the management of primary open angle glaucoma (POAG), has good clinical outcomes and safety profiles. However, few studies have comprehensivel...

(This article belongs to the Special Issue Clinical Outcomes of Glaucoma Surgery: Visual Acuity, Effectiveness and Quality of Life)
  • Article
  • Open Access
1 Citations
3,717 Views
24 Pages

Developing a Chromatographic Method for Quantifying Latanoprost and Related Substances in Glaucoma Treatments

  • Katarzyna Asendrych-Wicik,
  • Katarzyna Malik and
  • Magdalena Markowicz-Piasecka

24 April 2025

Background/Objectives: Latanoprost is a leading active pharmaceutical ingredient belonging to the synthetic prostaglandin F2α analogs, widely used as a first-line treatment for open-angle glaucoma and increased intraocular pressure. This study...

(This article belongs to the Special Issue Advances in Drug Analysis and Drug Development)